Evidence map›Paper›PMID 40844725›Full record

ReviewJournal of assisted reproduction and genetics2025

Exploring the epigenetic mechanisms of recurrent pregnancy loss: from genetic predisposition to environmental influences.

Yongquan Zheng, Dan He, Xiaoyu Cai, Xiaoqian Zhang, Caihong Zheng, Yao Yao

Abstract readReview
In one paragraph

Review in Journal of assisted reproduction and genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yongquan Zheng *Department of Pharmacy, Women's Hospital, Zhejiang University School of Medicine, No. 1 Xueshi Road, Shangcheng District, Hangzhou, 310006, China.ORCID http://orcid.org/0000-0002-6091-8265
Dan He *Department of Pharmacy, Women's Hospital, Zhejiang University School of Medicine, No. 1 Xueshi Road, Shangcheng District, Hangzhou, 310006, China.ORCID http://orcid.org/0000-0002-0288-0529
Xiaoyu CaiDepartment of Pharmacy, Hangzhou First People's Hospital, Hangzhou, 310006, China.ORCID http://orcid.org/0000-0002-8510-2967
Xiaoqian ZhangDepartment of Pharmacy, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.
Caihong ZhengDepartment of Pharmacy, Women's Hospital, Zhejiang University School of Medicine, No. 1 Xueshi Road, Shangcheng District, Hangzhou, 310006, China. chzheng@zju.edu.cn.ORCID http://orcid.org/0009-0000-1588-242X
Yao YaoDepartment of Pharmacy, Women's Hospital, Zhejiang University School of Medicine, No. 1 Xueshi Road, Shangcheng District, Hangzhou, 310006, China. yaoyaofb@zju.edu.cn.ORCID http://orcid.org/0000-0002-4560-6861

Funding

Huadong Medicine Joint Funds of the Zhejiang Provincial Natural Science Foundation of China LHDMZ23H190002
6 · The paper itself

Abstract

Recurrent pregnancy loss (RPL) is a complex and emotionally distressing condition defined by the occurrence of two or more consecutive miscarriages before 20 weeks of gestation. The exact causes of RPL remain unclear, despite extensive research into its genetic, immune, and environmental underpinnings. Recent advances in epigenetics have revealed that alterations in DNA methylation, histone modifications, and non-coding RNA expression play crucial roles in regulating pregnancy-related processes such as immune tolerance, placental development, and embryo implantation. These epigenetic changes are influenced not only by genetic predisposition but also by environmental factors, highlighting the dynamic interaction between genes and the environment in the pathogenesis of RPL. This review explores the role of epigenetics in RPL, focusing on the identification of epigenetic biomarkers, their potential for early diagnosis and prediction, and their implications for targeted therapeutic interventions. We also discuss how environmental factors, including diet, stress, and pollutants, can modify epigenetic regulation, potentially increasing the risk of RPL. Furthermore, emerging epigenetic-based therapies, such as epigenetic drugs and gene editing, are discussed as potential approaches to improving pregnancy outcomes in women with RPL. This review underscores the need for further research to translate epigenetic findings into clinical applications for personalized and precision medicine in RPL management.

Indexed as

Abortion, HabitualEpigenesis, GeneticGenetic Predisposition to DiseaseDNA MethylationEmbryo ImplantationFemaleGene-Environment InteractionHumansPregnancyDNA methylationEpigenetic mechanismsEpigenetic therapeuticsGene-environment interactionRecurrent pregnancy loss

Identifiers

PMID40844725
PMCPMC12640419

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.